Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective evaluation on the effects of anamorelin on blood zinc level and changes in grip strength in advanced gastrointestinal cancer patients with cancer cachexia

Next Previous
Trial Profile

Prospective evaluation on the effects of anamorelin on blood zinc level and changes in grip strength in advanced gastrointestinal cancer patients with cancer cachexia

Status: Not yet recruiting
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anamorelin (Primary)
  • Indications Cachexia
  • Focus Therapeutic Use
  • Acronyms anamo-zinc

Most Recent Events

  • 20 Aug 2021 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top